INR 68.1
(-0.01%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 12.73 Million | 12.1 Million | 12.01 Million | 10.66 Million | 9.62 Million | 5.23 Million |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | 12.73 Million | 12.1 Million | 12.01 Million | 10.66 Million | 9.62 Million | 5.23 Million |
Operating Expenses | 1.33 Million | 3.44 Million | 3.1 Million | 3.21 Million | 2.71 Million | 1.35 Million |
Selling, General and Administrative Expenses | 1.33 Million | 1.19 Million | 1.22 Million | 1.08 Million | 600.9 Thousand | 227.9 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 1.33 Million | 3.44 Million | 3.1 Million | 3.21 Million | 2.71 Million | 1.35 Million |
Operating Income | 11.39 Million | 8.66 Million | 8.9 Million | 7.45 Million | 6.9 Million | 3.88 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 1.6 Million | 1.54 Million | 1.7 Million | 1.32 Million | 1.3 Million | 800 Thousand |
Earnings before Tax | 8.75 Million | 8.66 Million | 8.9 Million | 7.45 Million | 7.04 Million | 3.89 Million |
Net Income | 7.15 Million | 7.12 Million | 7.2 Million | 6.12 Million | 5.74 Million | 3.09 Million |
Earnings Per Share Basic | 2.38 | 2.37 | 2.40 | 2.04 | 1.91 | 1.03 |
Earnings Per Share Diluted | 2.38 | 2.37 | 2.40 | 2.04 | 1.91 | 1.03 |
Weighted Average Shares Outstanding | 3 Million | 3 Million | 3 Million | 3 Million | 3 Million | 3 Million |
Weighted Average Shares Outstanding (Diluted) | 3 Million | 3 Million | 3 Million | 3 Million | 3 Million | 3 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 0.21 | - | -0.00 | - | 0.01 | 0.00 |
Profit Margin | 0.56 | 0.59 | 0.60 | 0.57 | 0.60 | 0.59 |
EBITDA | 2.64 Million | 13.17 Million | -1.00 | 11.7 Million | 138.79 Thousand | 7340.00 |
Earnings Before Tax Margin | 0.89 | 0.72 | 0.74 | 0.70 | 0.72 | 0.74 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 3.38 Million | 3.51 Million | 12.73 Million | 3.08 Million | 3.13 Million | 3 Million |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | 3.38 Million | 3.51 Million | 12.73 Million | 3.08 Million | 3.13 Million | 3 Million |
Operating Expenses | 1.73 Million | 961.91 Thousand | 3.98 Million | 718 Thousand | 800.99 Thousand | 1.5 Million |
Selling, General and Administrative Expenses | 324 Thousand | 365.64 Thousand | - | 324 Thousand | 324 Thousand | 324 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 1.73 Million | 961.91 Thousand | 3.98 Million | 718 Thousand | 800.99 Thousand | 1.5 Million |
Operating Income | 1.65 Million | 2.55 Million | 8.75 Million | 2.36 Million | 2.33 Million | 1.49 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 300 Thousand | 400 Thousand | 1.6 Million | 400 Thousand | 500 Thousand | 300 Thousand |
Earnings before Tax | 1.65 Million | 2.55 Million | 8.75 Million | 2.36 Million | 2.33 Million | 1.49 Million |
Net Income | 1.35 Million | 2.15 Million | 7.15 Million | 1.96 Million | 1.83 Million | 1.19 Million |
Earnings Per Share Basic | 0.45 | 0.72 | - | 0.65 | 0.61 | 0.40 |
Earnings Per Share Diluted | 0.45 | 0.72 | - | 0.65 | 0.61 | 0.40 |
Weighted Average Shares Outstanding | 3 Million | 2.98 Million | 3 Million | 3.02 Million | 3.01 Million | 2.99 Million |
Weighted Average Shares Outstanding (Diluted) | 3 Million | 2.98 Million | 3 Million | 3.02 Million | 3.01 Million | 2.99 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | - | - | - | -0.00 | -0.00 | - |
Profit Margin | 0.40 | 0.61 | 0.56 | 0.64 | 0.59 | 0.40 |
EBITDA | - | - | - | -1000.00 | -1000.00 | - |
Earnings Before Tax Margin | 0.49 | 0.73 | 0.69 | 0.77 | 0.75 | 0.50 |
MORARKFI
WONDF
BIOPOR
FBPA
YULE
NVG